-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

311.O1.6 311. Disorders of Platelet Number or Function: Heparin-Induced Thrombocytopenia and Immune Thrombocytopenia

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Biological, antibodies, Adult, autoimmune disorders, Drug-induced thrombocytopenia, Bleeding and Clotting, Diseases, Therapies, HIT, platelets, Biological Processes, immunodeficiency, Thrombosis, Immune Disorders, Platelet Disorders, Technology and Procedures, immunotherapy, Cell Lineage, Study Population, Clinically relevant, Thrombocytopenias, flow cytometry, immune mechanism, pathways
Saturday, December 5, 2020: 7:30 AM-9:00 AM
Jenny M. Despotovic, DO, MS, Texas Children's Hospital/Baylor College of Medicine and Hanny Al-Samkari, MD, Massachusetts General Hospital
Al-Samkari: Agios: Consultancy, Research Funding; Dova: Consultancy, Research Funding; Amgen: Research Funding; Argenx: Consultancy; Rigel: Consultancy.
7:30 AM

José Miguel Alvarez Blanco, MD, Ana Sierra Salazar, MD*, Juan Rangel-Patiño, MD and Roberta Demichelis, MD

Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

7:45 AM

Sanjay Khandelwal, PhD1, Lubica Rauova, MD, PhD2, Ayiesha Barnes, MS1*, Ann Rux3*, Serge Yarovoi3*, Sooho S Myoung1*, Alexandra Johnson1*, Grace M Lee, MD1, Madelaine Duarte, BA1*, Mortimer Poncz, MD2, Gowthami M. Arepally, MD1 and Douglas B. Cines, MD3

1Division of Hematology, Duke University Medical Center, Durham, NC
2Children's Hospital of Philadelphia, Philadelphia, PA
3Department of Pathology and Laboratory Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA

8:00 AM

Maria Selvadurai, PhD, BSc1,2*, Christine Lee1*, James Yeung, MBBS1,3*, Maria Konda4*, Geoffrey Kershaw1,5*, Emmanuel Favaloro6,7,8* and Vivien Chen, PhD MBBS1,3

1ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia
2Faculty of Medicine, Nursing and Health Sciences, Monash University, St Kilda East, VIC, Australia
3Department of Haematology, Concord Repatriation General Hospital, Sydney, NSW, Australia
4Diagnostic Pathology Unit, Concord Repatriation General Hospital, Sydney, NSW, Australia
5Institute of Haematology, Royal Prince Alfred Hospital, Sydney, NSW, Australia
6Sydney Centres for Thrombosis and Haemostasis, Westmead, NSW, Australia
7School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia
8Westmead Hospital, Westmead, NSW, Australia

8:15 AM

Shawn Jindal, MD1*, Christopher Leyton, MD2*, Fred Cohen, MD2*, Morayma Reyes Gil, MD, PhD3* and Henny H. Billett, MD, MSc4

1Department of Internal Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, New York, NY
2Department of Internal Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
3Department of Pathology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY
4Division of Hematology, Department of Internal Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

8:30 AM

David J. Kuter, MD1, Merlin Efraim, MD2*, Jiri Mayer, MD3, Vickie McDonald, MD4*, Robert J. Bird, FRACP, FRCP, FRCPA, MBBS, MRCP5*, Thomas Regenbogen, MD6*, Mamta Garg, MD, FRCP, FRCPath7*, Zane Kaplan, MBBS(Hons) BMedSc(Hons) PhD FRACP FRCPA8, Olga Bandman, MD9*, Regan Burns9*, Ann Neale9*, Dolca Thomas, MD9* and Nichola Cooper, MD, MRCP10

1Hematology Division, Massachusetts General Hospital, Boston, MA
2Multiprofile Hospital for Active Treatment Sveta Marina EAD, Varna, Bulgaria
3Department of Internal Medicine, Hematology and Oncology, Masaryk University Hospital, Brno, Czech Republic
4Barts Health NHS Trust, The Royal London Hospital, London, United Kingdom
5Department of Haematology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
6MidMichigan Medical Center, Midland, MI
7Leicester Royal Infirmary, Leicester, United Kingdom
8Monash Medical Center, Clayton, Victoria, Australia
9Principia Biopharma Inc., South San Francisco
10Department of Medicine, Hammersmith Hospital, London, United Kingdom

8:45 AM

Catherine M. Broome1*, Alexander Röth, MD2, David J. Kuter, MD3, Marie Scully, MD4, Roy Smith5, Jennifer Wang6*, Xiaoyu Jiang6*, Caroline Reuter6*, Ahmed Daak6* and William Hobbs6

1Division of Hematology, MedStar Georgetown University Hospital, Washington, D.C.
2Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
3Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
4Department of Haematology, University College London Hospitals, Cardiometabolic Program, National Institute for Health Research UCLH/UCL Biomedical Research Centre, London, United Kingdom
5Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA
6Sanofi, Waltham, MA

*signifies non-member of ASH